Menu

Blog

Mar 30, 2023

Study indicates interleukin-6-dependant pathway dysregulation as a key druggable feature of COVID-19

Posted by in category: biotech/medical

In a recent study on the medRxiv preprint server, researchers identified an interleukin 6 (IL-6) dependent alternative pathway as a therapeutic strategy against coronavirus disease 2019 (COVID-19).

Study: A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19. Image Credit: MarynaOlyak/Shutterstock.com

1

Comment — comments are now closed.


  1. NMIMS Distance MBA is a program offered by Narsee Monjee Institute of Management Studies (NMIMS) through their distance learning division, working professionals